ObsEva (CHIX:OBSNZ) Other Net Income (Loss) : CHF-0.00 Mil (TTM As of Dec. 2022)

View and export this data going back to 2018. Start your Free Trial

What is ObsEva Other Net Income (Loss)?

ObsEva's Other Net Income (Loss) for the three months ended in Dec. 2022 was CHF0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2022 was CHF-0.00 Mil.

ObsEva's quarterly Other Net Income (Loss) increased from Jun. 2022 (CHF-0.00 Mil) to Sep. 2022 (CHF0.00 Mil) but then stayed the same from Sep. 2022 (CHF0.00 Mil) to Dec. 2022 (CHF0.00 Mil).

ObsEva's annual Other Net Income (Loss) declined from Dec. 2020 (CHF0.00 Mil) to Dec. 2021 (CHF-0.00 Mil) but then increased from Dec. 2021 (CHF-0.00 Mil) to Dec. 2022 (CHF0.00 Mil).

ObsEva Other Net Income (Loss) Historical Data

The historical data trend for ObsEva's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ObsEva Other Net Income (Loss) Chart

ObsEva Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Net Income (Loss)

Get a 7-Day Free Trial

ObsEva Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

ObsEva Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-0.00 Mil.

ObsEva Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of ObsEva's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

ObsEva (CHIX:OBSNZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ObsEva SA (CHIX:OBSNz) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Chemin des Aulx, 12, Plan-les-Ouates, Geneva, CHE, 1228

Website

https://www.obseva.com

ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of innovative women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.

ObsEva (CHIX:OBSNZ) Headlines

No Headlines